home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 30, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 689 active entries

BioMedicine Cytotherapy Company

Chicago, IL 60637
60637
United States of America, Illinois

Phone: http://virusdecoder.com
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

SARS‧Virus‧Cancer‧Carcinomatosis‧Chronic Disease Solution‧BioMedicine CytoTherapy

CytoThesis˙BrainNeuroSignals˙VasoHeart˙NeuroHormone
Colony Stimulating Factor˙Outflanking˙Intercept˙Water Channel˙NephroGene

The world's Top SARS & Virus Decoding - BioMedicine CytoTherapy

Virusdecoder.com is a vertical integrated BioMedical firm that the BioMedicine & BioTechnology R&D, Manufacturing, Production, Proteomics, Metabolomics, Physiopathology, Pathogenesis, Cytotherapy, Immunotherapy, Oncotherapy, BioDiagnostics, and BioTherapeutics are conducted within the corporate itself.

Since 2002 we have successfully developed Natural BioMedical PolyPeptide GlycoProteins & Herbs MediFormula that is all-round solution to human disease and healthcare. We have started our R&D for more than 20 years since 1981 and the life science since 1990, and to act as outsourcing R&D team for global pharmaceutical and nutraceutical corporate.

Human (Major Histocompatibility Complex) MHC Molecules were first discovered in 1900 when scientists tried to propagate tumors, to named by Dr. George Snell who won the Nobel Prize in 1980, and to Dr. Peter C. Doherty and Dr. Rolf M. Zinkernagel (Nobel Prize 1996 in Physiology & Medicine) study to demonstrate Immune Defense related to MHC. Our research always keep and upgrade MHC at any moment, and by top bio- & nano- technologies, successfully finish related natural MediFormula as dietary supplements without side effect.

VirusDecoder (I)

VirusDecoder is Virus Conqueror. It can strongly activate Cell Actin Cytoskeleton, T-LAK (T-Lymphokine-Activated Killer) and PMN (Polymorphonuclear) Leukocytes involved in tumor rejection, suppress tumor cell proliferation, mediate antitumor and oncocytic activity, and to activate bacteriolysis, bacteriophagy and rivustatic activity. It can significantly make healthcare and disease solution, specially for significant Anti-Viruses as HIV (Human Immunodeficiency Virus, AIDS), HCMV(Human Cytomegalovirus), Influenza Virus as Orthomyxovirus, RhinoViruses (Cold Virus), EnteroVirus, HerpesVirus, HPV (Human PapillomaVirus), HTLV (Human T-cell Leukemia Virus), AdenoVirus, Hepatitis Virus (A, B, C), DNA & RNA Tumor Virus, and significant Anti-Bacteria as MRSA (Methicillin Resistant Staphylococcus aureus), Streptococcus Pneumoniae, VRE: Vancomycin-Resistant Enterococci, Enterobacter sp, H.P. (Helicobacter Pylori), Pseudomonas aeruginosa, and treatment of significant Chronic Disease such as Hepatocarcinoma, Nasopharyngeal Cancer, large intestine Cancer, Cervical cancer, Hepatoma, Metrocarcinoma, (Lung) Adenocarcinoma, Carcinomatosis, Leukemia, Diabetes, Hypertension, Heart Disease, Cardiac Arrhythmia, Rheumatoid Arthritis, Hepatitis, Tuberculosis, Influenza Pneumonia, Vasculitis, Warts, Gonorrhea, Genital Candidiasis, Chancre, Gumma,and…etc.

We utilize a profound understanding of life science and biological science from fundamental and applied research for R&D. Within CytoTherapy.US itself, we possess expertise in biological science that many biotech firms are striving for. Based on our strong base of know-how, the time span of our R&D is significantly shortened in new product development.

It is natural peptide proteins and glycoside of herbal extracts we utilize as material for ingredient. Our research of the characteristics of proteins and herbs has been completed best active herbal & polypeptide glycoproteins. This competency differentiates us from other competitors in the industry. It illustrates that we possess incompatible expertise in proteins and herbal material interrelated to life science and disease treatment. Subsequently, competitors in the sector of proteins and phytomedicine will turn into our material suppliers.

Our completed clinical research will serve different needs among biotech firms to enrich their product lines and enhance the efficacy of their products. Taken as a whole, the sustainable competitive advantage within our products and know-how is far from possibility for existing and potential competitors to replicate.

We have successful case to rescue SARS (Severe Acute Respiratory Syndrome) patients in Hong Kong as following list and completely to cure Carcinomatosis and identified by event doctor. SARS Solution is no problems to us. VirusDecoder is SARS conqueror.

SARS successfully cured case in Hong Kong
1) Hospitalization: Prince of Wales Hospital (Hong Kong)
2) SARS Inpatient: Minister of Religion (Pastor) : Mr. Hsieh (Yaw Yang Hsieh)
3) Background: Squarson of Chinese Christian Propaganda
4) Event: In Intensive Care Unit (ICU), hyperpyrexia fadelessly many a long day, to mantle oxygen encasing. But, biomedical mediformula intaked in time and just one day, hyperpyrexia faded, transferred to general 8A sickroom in 2003/03/24. Complete recovery and go home 03/30 afternoon.
5) Witness: Ms. Hsieh (Yann Jiun Hsieh) (young sister of Inpatient Mr. Hsieh)
6) Background: Missioner of Chinese Christian Propaganda

VirusDecoder (II)

strongly to support Cell Actin Cytoskeleton, promote InterLeukin-2 from Helper CD4+ Cells regulating Acquired Immune System Activity, proceeding to supply the necessary Cytokines for Immune Responses against Antigen they recognize, actuating Helper T-Cell binding MHC II-Peptide Complex activating CD8+ Cells for Peptide Identification as recognizer to destroy any cell hosting Viruses and Mutant Cells as Cancer, Tumors, Tuberculosis, IntraCellular Infections. VirusDecoder is natural peptide bond proteins carring & chelating herbal extracts 35g powder / bottle as best Dietary Supplement and Nutraceuticals for children, kiddie, teenager, juvenile and adults each 1-2 spoon/0.5g after 2-3 meals daily.

VirusDecoder, each bottle is US$1,250 including global courier delivery. Please Purchaser directly email advise us your buying quantities, Recipients (addressee), detailed receiving address and communicant phone and mobile for speed courier advice with you and check receiving address. We will email reply reimbursing account after receipt of above purchaser's detailed information.

From sources of BCC, Inc. July 2000, Global present peptide proteins existing in top expense for US$470,000/g and even up to 2003 for US$600,000 per one gram. In the 21th century, you shall find your healthcare and disease solution is established from activating vitality and cell by peptide proteins & glycoproteins with world's top heavy cost money by an arm and a leg. However, it is exactly very update now and rescue your life and cells for renewal and regeneracy. Of course, it definitely come in being all-round and even all-inclusive healthcare and disease solution. Please refer to following biotech cost:

http://www.genscript.com/cgi-bin/products/rec_peptide.cgi
http://www.researchd.com/humanag/humags.htm

http://virusdecoder.com
Email: virusdecoder@virusdecoder.com

Note: The Food & Drug administration has not evaluated these claims. Always check with your doctor before starting a nutritional supplement program. This is an independant web site and is not endorsed by Cytotherapy.US.

The New England Journal of Medicine
Volume 347:2046-2056 December 19, 2002 Number 25

Herbal medicine is an increasingly common form of alternative therapy in the United States. A 1997 survey estimated that 12.1 percent of adults in the United States had used an herbal medicine in the previous 12 months (as compared with 2.5 percent in 1990), resulting in out-of-pocket payments of $5.1 billion.1 Among those who had used herbal medicine, 15.1 percent had seen an alternative-medicine practitioner, with a total of 10.5 million office visits, 19.8 percent of which had been completely or partially covered by insurance. In 2001, $17.8 billion was spent in the United States on dietary supplements, $4.2 billion of it for herbs and other botanical remedies.

Regulation

Most herbal products in the United States are considered dietary supplements and thus are not regulated as medicines and are not required to meet the standards for drugs specified in the Federal Food, Drug, and Cosmetic Act. The only requirement is that these preparations meet the standards set forth in the 1994 Dietary Supplement and Health Education Act (DSHEA). Herbal products may be produced without the assurance of compliance standards for Good Manufacturing Practice (although such standards are being developed), and they are marketed without prior approval of their efficacy and safety by the Food and Drug Administration (FDA). According to the DSHEA, the manufacturer of an herbal preparation is responsible for the truthfulness of claims made on the label and must have evidence that the claims are supported, yet the DSHEA neither provides a standard for the evidence needed nor requires submission of the evidence to the FDA. Under the DSHEA, the manufacturer is permitted to claim that the product affects the structure or function of the body, as long as there is no claim of effectiveness for the prevention or treatment of a specific disease, and provided there is a disclaimer informing the user that the FDA has not evaluated the agent. Some of the claims on the labels of herbal products suggest that they can be used to treat disease, and accompanying materials, produced by persons other than the manufacturer, that overtly promote such use may be available where the herbal remedies are sold. According to the DSHEA, the manufacturer is responsible for controlling quality and safety, but if a concern about safety arises, the burden of proof lies not with the manufacturer but with the FDA, which has to prove that the product is unsafe.

in the title: “Recent patterns of medication use in the ambulatory adult population of the United States” in JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 287: (3) 337-344 JAN 16 2002, conclusions: Herbals/supplements were taken by 14% of the population. Among prescription drug users, 16% also took an herbal/supplement. In any given week, most US adults take at least 1 medication, and many take multiple agents. The substantial overlap between use of prescription medications and herbals/supplements raises concern about unintended interactions. Documentation of usage patterns can provide a basis for improving the safety of medication use.

CytoTherapy.US HealthCare & BioMedicine including:
‧Pharmaceuticals & Therapeutics
‧Chronic Disease Treatment
‧Biotechnology
‧Herbal Alternative Medicine
‧Chronic Disease Treatment
‧Longevity & Life Expectancy
‧Holistic & Integrated Medicine
‧Anti-Aging

Chinese Presentation: http://virusdecoder.com/123



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Diagnostics
- Medical
Pharmaceutical
- Research
Supplier
- Medical
Consulting
- Strategic
Contract
- Production

Last update of this entry: September 06, 2013

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.